Skip to main content
Premium Trial:

Request an Annual Quote

Thermo Fisher, Winvale Group Ink Informatics Partnership

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – The Winvale Group, a government procurement and consulting organization specializing in government procurement and the General Services Agency Schedule program, has partnered with Thermo Fisher Scientific to help it land informatics customers that are using stimulus funding, Thermo Fisher said today.

As part of Thermo Fisher's Informatics Global Partner Alliance, Winvale will help Thermo Fisher navigate the GSA Schedule 70 information technology contracting process.

Winvale also will ensure that Thermo Fisher's informatics solutions, such as its laboratory information management systems or chromatography data systems can be acquired using funding from the American Recovery and Reinvestment Act of 2009.

Thermo Fisher said that the partnership is part of its efforts to "reach the critical audience of federal, state, and local laboratories that require IT solutions to manage a full range of scientific and laboratory research, from public health and safety laboratories to drinking water and public sanitation, environmental and state and federal research institutes."

The Scan

Study Reveals Details of SARS-CoV-2 Spread Across Brazil

A genomic analysis in Nature Microbiology explores how SARS-CoV-2 spread into, across, and from Brazil.

New Study Highlights Utility of Mutation Testing in Anaplastic Thyroid Cancer

Genetic mutations in BRAF and RAS are associated with patient outcomes in anaplastic thyroid carcinoma, a new JCO Precision Oncology study reports.

Study Points to Increased Risk of Dangerous Blood Clots in COVID-19 Patients

An analysis in JAMA Internal Medicine finds that even mild COVID-19 increases risk of venous thromboembolism.

Y Chromosome Study Reveals Details on Timing of Human Settlement in Americas

A Y chromosome-based analysis suggests South America may have first been settled more than 18,000 years ago, according to a new PLOS One study.